Among them was EGFR tyrosine kinase inhibitor resistance [15], PD-L1 expression, and PD-1 checkpoint pathway in cancer [16]; the T cell receptor signaling pathway and PI3K-Akt signaling pathway are closely associated with lung cancer and are therefore considered the main pathways of interest for further research [17,18]. The gene discussed is EGFR; the disease is cancer.